TABLE 8.
aCategory | Category identifier and name | P-value | bFDR P-value |
Cluster 1 | ES = 1.82 | ||
MF | GO:0005201∼extracellular matrix structural constituent | 3.0E-02 | 7.9E-01 |
Cluster 2 | ES = 1.74 | ||
KEGG | ssc04080:Neuroactive ligand-receptor interaction | 2.7E-06 | 2.4E-04 |
BP | GO:0009725∼response to hormone | 7.3E-04 | 9.4E-01 |
Cluster 3 | ES = 1.74 | ||
BP | GO:0048732∼gland development | 1.7E-03 | 5.7E-01 |
Cluster 4 | ES = 1.45 | ||
BP | GO:0007420∼brain development | 1.1E-01 | 7.9E-01 |
BP | GO:0030900∼forebrain development | 1.9E-01 | 8.7E-01 |
Cluster 5 | ES = 1.41 | ||
MF | GO:0020037∼heme binding | 6.2E-02 | 9.1E-01 |
MF | GO:0005506∼iron ion binding | 9.3E-02 | 9.3E-01 |
Cluster 6 | ES = 1.35 | ||
BP | GO:0009790∼embryo development | 5.8E-03 | 5.4E-01 |
BP | GO:0090596∼sensory organ morphogenesis | 8.9E-03 | 5.1E-01 |
aBP, biological process; MF, molecular function; KEGG, KEGG pathway. bFalse discovery rate adjusted P-value.